1. Strengthening academic platform construction.
The Chinese Bipolar Disorder Collaborative Group and the Working Committee on Bipolar and Related Disorders of the Psychiatrists Branch of the Chinese Medical Association shouldered their mission and performed their respective responsibilities, focusing on promoting the following work: (1) Promoting and popularizing knowledge of bipolar disorder diseases and increasing public awareness; (2) Strengthening training for specialist and non-specialist doctors, carrying out continuing education, establishing standardized clinical pathways for bipolar disorder, improving recognition rates and promoting standardized treatment, and carrying out (3) Leading multicentre, large sample epidemiological surveys and clinical studies to provide high-quality evidence-based evidence for the diagnosis and treatment of bipolar disorder; (4) Promoting multidisciplinary collaboration to explore disease characteristics, pathogenesis, treatment strategies and innovative diagnostic and treatment techniques.
2. Seize strategic development opportunities.
With the increase in national investment in medical research in recent years, bipolar disorder research is facing an important strategic opportunity for development. It is our pursuit to grasp the development opportunity, to work together with basic research scholars, to implement the concept of translational medicine, and to truly achieve the translation of clinical-research-clinical results. In addition, China is planning and implementing the "China Brain Project", and we need to think about how psychiatrists can make the most of clinical research on a national research platform to avoid being marginalised.
3. Development of precision medicine models.
The study of biological markers (including characteristic cognitive impairment) is currently a hotspot in the field of bipolar disorder research, and a breakthrough in this area is expected in the future. As a result, sensitivity/specific tests, screening, early diagnosis and prognosis of biological markers will be possible. The implementation of a precision medicine model based on these findings will greatly improve the outcome and prognosis of bipolar disorder and help reduce the cost of care. Therefore, there is a need for extensive and in-depth collaboration between Chinese colleagues to promote individualised treatment based on standardised treatment for bipolar disorder.
"It is expected that the psychiatric and neuroscientific communities in China will consolidate the achievements of the past efforts and work together to build a brilliant future for the clinical diagnosis and treatment of bipolar disorder and scientific research in China.
Comments